What LXE Hearing does

LXE Hearing is a hearing health technology company formed in April 2025 through the merger of US-based Eargo Inc. and South Africa's HearX Group, with $100 million in growth funding from Patient Square Capital. The company operates a portfolio of three complementary brands covering the full hearing care continuum: hearX provides clinically-validated, mobile hearing loss detection and diagnosis technology that does not require a soundproof booth and is deployed in over 70 countries; Eargo pioneered the direct-to-consumer category with virtually invisible hearing aids sold through e-commerce; and Lexie Hearing (Powered by Bose) is described as the #1 OTC hearing aid brand in the U.S., with products sold in more than 16,000 retail stores nationwide. The combined entity is headquartered in San Jose, California, with 101-250 employees, and was named among TIME's 100 Most Influential Companies in 2023 for the Lexie brand.

The company's core technology stack spans miniaturized hearing aid hardware (Eargo's virtually invisible form factor), co-developed OTC hearing aid technology under the Bose partnership (Lexie), and mobile audiometric screening platforms validated for clinical use without specialized infrastructure (hearX). Flagship products include the Eargo 7 and Lexie B2 hearing aids. The combined portfolio addresses the full patient journey from initial detection and diagnosis through intervention for mild to moderate hearing loss.

LXE Hearing generates revenue primarily through hardware sales of hearing aids and hearing health products across its three brands. The go-to-market model is hybrid by brand: Eargo sells direct-to-consumer online, Lexie distributes through mass retail partnerships, and hearX deploys its technology globally via health system and screening program channels. The company serves two primary customer segments: consumers with mild to moderate hearing loss seeking accessible, stigma-free solutions, and healthcare providers and screening programs in resource-limited settings. The executive team includes Interim CEO Adam Karp, CTO Tim Trine, CFO Emanuel Gerson, and CCO Brian Maguire.

Name

LXE Hearing

Legal name

LXE Hearing

Website

https://lxehearing.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

101–250 employees

Short description

LXE Hearing is a hearing health technology company operating three complementary brands—Eargo (direct-to-consumer invisible hearing aids), Lexie Hearing (OTC hearing aids via 16,000+ retail stores, Powered by Bose), and hearX (mobile hearing diagnostics in 70+ countries)—serving consumers with mild to moderate hearing loss and healthcare providers globally.

Ownership category

akta.pro rank

Product category

Hearing Aids and Hearing Health Technology

NAICS

All Other Outpatient Care Centers (621498)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Non-prescription / OTC Digital Therapeutics (HLACANAC)

Keywords

• OTC hearing aids
• Hearing health technology
• Hearing loss detection
• Direct-to-consumer hearing aids
• Mobile audiometry

Headquarters

HQ city

San Jose

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Hearing Aid Product Sales: LXE Hearing generates revenue through the sale of hearing aids and hearing health products across its three portfolio brands: Eargo, Lexie Hearing, and hearX. Products range from OTC self-fitted devices to professional diagnostic technologies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

LXE Hearing is a hearing health company that operates a portfolio of three complementary brands spanning the full hearing care continuum. It sells over-the-counter (OTC) hearing aids direct to consumers (Eargo virtually invisible hearing aids) and through 16,000+ U.S. retail stores (Lexie Hearing, Powered by Bose), and distributes clinically-validated mobile hearing loss detection and diagnosis technology (hearX) to healthcare providers in 70+ countries without requiring a soundproof booth.

Product overview

LXE Hearing operates as a hearing health company offering a portfolio of complementary brands. The company provides a full suite of hearing technology spanning from detection and diagnosis (hearX) to intervention of hearing loss (Eargo and Lexie Hearing OTC hearing aids). The portfolio brands work together to cover the hearing health continuum: hearX enables hearing loss detection and diagnosis without requiring a soundproof booth; Eargo offers virtually invisible direct-to-consumer hearing aids; and Lexie Hearing (Powered by Bose) is the #1 OTC hearing aid brand in the U.S. sold through major retail channels.

Differentiator

Problem solved

Functional benefit

Brands

• Eargo: Pioneer in offering hearing aids direct to consumers with innovative, virtually invisible products that address challenges of traditional hearing aid adoption including social stigma and accessibility.
• Lexie Hearing
• hearX

Products and services

• Eargo OTC Hearing Aids

Quantifiable outcome

• Over-the-counter hearing aids market projected to reach $1.82 billion by 2030

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• HearX GroupflagshipStrategic or Co-development Partner · 1 April 2025In April 2025, US-based Eargo Inc. merged with South Africa's HearX Group to form LXE Hearing. This strategic alliance combined expertise in product design and technology innovation to disrupt and reimagine the hearing industry. The merger created a company with global reach spanning over 70 countries and a full suite of hearing technology brands.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Sonova: Sonova is one of the world's largest hearing aid manufacturers (Phonak, Unitron, Hansaton) and a leader in cochlear implants. Comparable to LXE as a broad incumbent across hearing devices, with overlapping end-customers and overlapping channel approach through audiologists and select retail/OTC expansion.
• WS Audiology: WS Audiology is the parent of Widex, Signia, Sivantos brands and is a top global hearing aid manufacturer. Comparable as a broad incumbent with overlapping hearing aid product portfolio and professional/retail channels serving the same consumer demographic.
• Demant: Demant owns Oticon, Bernafon, Sonic and Philips Hearing Aids, making it a top-3 global hearing aid incumbent. Comparable to LXE as a broad incumbent selling hearing instruments and diagnostics through professional and increasingly consumer channels, competing for the same end-user demographic.

Direct peers

• Bose: Bose is both a strategic partner (Lexie's "Powered by Bose" line) and a direct competitor through its Bose SoundControl OTC hearing aid. Comparable as a direct competitor in OTC hearing aids and consumer audio devices targeting the same mild-to-moderate hearing loss segment.
• MDHearing: MDHearing is a U.S.-based direct-to-consumer hearing aid retailer selling affordable, self-fit devices primarily online. Comparable as a direct peer competing with Eargo in the DTC hearing aid category and targeting the same value-conscious consumer with mild-to-moderate hearing loss.
• GN Group: GN Group owns ReSound, Beltone and Jabra and is one of the world's largest hearing aid manufacturers. Highly comparable as a direct peer — overlapping product portfolio (hearing aids and hearables), overlapping channels (professional and retail/OTC), and an active competitor in the OTC hearing aid space through Jabra Enhance.
• Audicus: Audicus is a U.S.-based direct-to-consumer hearing aid company offering affordable online-purchased devices. Highly comparable as a direct peer competing head-to-head with Eargo in the DTC channel, targeting the same mild-to-moderate hearing loss segment with subscription and one-time purchase models.
• Starkey Hearing Technologies: Starkey is one of the largest U.S.-headquartered hearing aid manufacturers, offering a full line of prescription and OTC hearing devices. Highly comparable as a direct peer — competing in the same hearing aid category with overlapping retail and professional channels and overlapping end-customers.

Emerging players

• Sony: Sony entered the OTC hearing aid market via a partnership with WS Audiology, leveraging its consumer electronics brand to sell self-fitting devices. Comparable as an emerging player in OTC hearing aids, competing for the same price-sensitive consumer segment and leveraging similar retail channels.
• Nuheara: Nuheara is an Australia-based hearing technology company selling smart hearing buds (e.g., IQbuds) that combine consumer earbuds with hearing assistance features. Comparable as an emerging player in the hearables/PSAP/OTC overlap space, targeting tech-forward consumers with mild hearing needs.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/LXEHearing

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LXE Hearing